Expression of tissue factor in high-grade carotid artery stenosis: Association with plaque destabilization

Stroke

Volumn 32, Issue 4, 2001, Pages 850-854

  Jander, Sebastian ^a   Sitzer, Matthias ^b   Wendt, Angélique ^a   Schroeter, Michael ^a   Buchkremer, Martin ^b   Siebler, Mario ^a   Müller, Wolfram ^a   Sandmann, Wilhelm ^a   Stoll, Guido ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Carotid arteries; Inflammation; Leukocytes; Procoagulant

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; ENDARTERECTOMY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERNAL CAROTID ARTERY OCCLUSION; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035071754     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.4.850     Document Type: Article

References (33)

1. Mechanisms of acute carotid stroke
2. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours
3. Natural history of asymptomatic extracranial arterial disease
4. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis
5. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
6. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography
7. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis
8. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis
9. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis
10. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis: Event rates before and after carotid endarterectomy
11. Atherosclerosis: An inflammatory disease
12. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
13. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
14. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition? A proteoglycan substrate for the enzyme
15. Localization of tissue factor in human atherosclerotic plaques by binding of digoxygenin-labeled factors VIIa and X
16. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis
17. The pathogenesis of coronary artery disease and the acute coronary syndromes (1)
18. Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis
19. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis
20. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque
21. Inflammation in high-grade carotid stenosis: A possible role for macrophages and T cells in plaque destabilization
22. The symptomatic carotid plaque
23. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes
24. Cell biology of tissue factor, the principal initiator of blood coagulation
25. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
26. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
27. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
28. North American Symptomatic Carotid Endarterectomy Trial: Methods, patient characteristics, and progress
29. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: A potential role in acute plaque disruption
30. Tissue factor pathway inhibitor expression in atherosclerosis
31. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis
32. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels
33. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity